AU4552597A - Pharmaceutical composition containing lornoxicam and a disodic salt of edta - Google Patents
Pharmaceutical composition containing lornoxicam and a disodic salt of edtaInfo
- Publication number
- AU4552597A AU4552597A AU45525/97A AU4552597A AU4552597A AU 4552597 A AU4552597 A AU 4552597A AU 45525/97 A AU45525/97 A AU 45525/97A AU 4552597 A AU4552597 A AU 4552597A AU 4552597 A AU4552597 A AU 4552597A
- Authority
- AU
- Australia
- Prior art keywords
- edta
- pharmaceutical composition
- composition containing
- lornoxicam
- disodic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A pharmaceutical composition is disclosed which contains lornoxicam and a disodic salt of EDTA.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0156496A ATA156496A (en) | 1996-09-03 | 1996-09-03 | PHARMACEUTICAL COMPOSITION |
AT1564/96 | 1996-09-03 | ||
PCT/EP1997/004742 WO1998009654A1 (en) | 1996-09-03 | 1997-09-01 | Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4552597A true AU4552597A (en) | 1998-03-26 |
Family
ID=3516134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45525/97A Abandoned AU4552597A (en) | 1996-09-03 | 1997-09-01 | Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0934079B1 (en) |
JP (1) | JP4122062B2 (en) |
CN (1) | CN1108822C (en) |
AT (2) | ATA156496A (en) |
AU (1) | AU4552597A (en) |
CA (1) | CA2264626C (en) |
DE (1) | DE59706450D1 (en) |
DK (1) | DK0934079T3 (en) |
ES (1) | ES2172002T3 (en) |
NO (1) | NO326350B1 (en) |
PT (1) | PT934079E (en) |
WO (1) | WO1998009654A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001172183A (en) * | 1999-12-21 | 2001-06-26 | Wakamoto Pharmaceut Co Ltd | Ophthalmic pharmaceutical composition |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10030345A1 (en) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Highly concentrated stable meloxicam solutions |
DE10161077A1 (en) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Highly concentrated stable meloxicam solutions for needleless injection |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
JO2735B1 (en) | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formulations of palonosetron |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
CN102647971B (en) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | For comprising the container of the compositions of meloxicam |
WO2011107150A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
WO2012127496A1 (en) | 2011-03-01 | 2012-09-27 | Cadila Healthcare Limited | Stable pharmaceutical compositions of lornoxicam or salts thereof |
CN106727364B (en) * | 2016-12-02 | 2020-01-24 | 苏州天马医药集团天吉生物制药有限公司 | Freeze-drying process of lornoxicam for injection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203703B (en) * | 1983-05-23 | 1989-02-15 | Bruschettin Srl | Storage stable antiinflammatory eye drops |
US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
AU5774796A (en) * | 1995-06-13 | 1997-01-09 | Dyer, Alison Margaret | Pharmaceutical compositions containing lornoxicam and cyclod extrin |
-
1996
- 1996-09-03 AT AT0156496A patent/ATA156496A/en not_active Application Discontinuation
-
1997
- 1997-09-01 AU AU45525/97A patent/AU4552597A/en not_active Abandoned
- 1997-09-01 DE DE59706450T patent/DE59706450D1/en not_active Expired - Lifetime
- 1997-09-01 DK DK97943820T patent/DK0934079T3/en active
- 1997-09-01 CN CN97197619A patent/CN1108822C/en not_active Expired - Lifetime
- 1997-09-01 CA CA002264626A patent/CA2264626C/en not_active Expired - Lifetime
- 1997-09-01 EP EP97943820A patent/EP0934079B1/en not_active Expired - Lifetime
- 1997-09-01 JP JP51222198A patent/JP4122062B2/en not_active Expired - Lifetime
- 1997-09-01 PT PT97943820T patent/PT934079E/en unknown
- 1997-09-01 AT AT97943820T patent/ATE213420T1/en active
- 1997-09-01 ES ES97943820T patent/ES2172002T3/en not_active Expired - Lifetime
- 1997-09-01 WO PCT/EP1997/004742 patent/WO1998009654A1/en active IP Right Grant
-
1999
- 1999-02-25 NO NO19990909A patent/NO326350B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2172002T3 (en) | 2002-09-16 |
CA2264626C (en) | 2009-03-24 |
WO1998009654A1 (en) | 1998-03-12 |
JP4122062B2 (en) | 2008-07-23 |
NO990909L (en) | 1999-02-25 |
PT934079E (en) | 2002-06-28 |
CA2264626A1 (en) | 1998-03-12 |
EP0934079B1 (en) | 2002-02-20 |
DK0934079T3 (en) | 2002-04-02 |
CN1108822C (en) | 2003-05-21 |
EP0934079A1 (en) | 1999-08-11 |
JP2000517331A (en) | 2000-12-26 |
DE59706450D1 (en) | 2002-03-28 |
ATE213420T1 (en) | 2002-03-15 |
ATA156496A (en) | 1997-10-15 |
NO326350B1 (en) | 2008-11-17 |
CN1228710A (en) | 1999-09-15 |
NO990909D0 (en) | 1999-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5967196A (en) | Set of endodontic instruments | |
AU7256296A (en) | Use of metallofluorocomplexes for dental compositions | |
AU8140898A (en) | Inhibitors of beta-lactamases and uses therefor | |
PL322877A1 (en) | Sulphonamidic inhibitors of aspartil hiv protease containing thf | |
AU4605896A (en) | Improved method of soft tip forming | |
AU7974794A (en) | Endodontic instrument of predetermined flexibility | |
PL323470A1 (en) | Application of n-propargil-1-amidoindane (r)-enantionmer, its salts and compositions containing same | |
AU5616896A (en) | Method of providing call charge information | |
PL327569A1 (en) | Promedications of thrombosin inhibitors | |
AU7727196A (en) | Oxygen generating compositions | |
AU7482396A (en) | Substituted aryl pyrroles, compositions containing such compounds and methods of use | |
AU5588096A (en) | Oral formulations of S(+)-etodolac | |
AU6485996A (en) | Methods and compositions for modulation and inhibition of teomerase | |
AU4552597A (en) | Pharmaceutical composition containing lornoxicam and a disodic salt of edta | |
AU699201B2 (en) | Highly fluidized concrete composition | |
AU6692996A (en) | Inhibitors of apoptosis | |
AU6517396A (en) | Preparation of N-substituted 3-hydroxypyrazoles | |
AU4702496A (en) | Oral compositions of h2-antagonists | |
AU4479096A (en) | 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 | |
ZA9610798B (en) | Inhibitors of interleuken-1beta converting enzyme | |
AUPN737295A0 (en) | Gasser composition & method of gassing | |
AU2966595A (en) | Method of polymerizing methacrylate-based compositions | |
AU4276496A (en) | 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use | |
AU5033296A (en) | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines | |
AU5077996A (en) | Coating compositions and methods of using them |